Magnitude of cancer drug shortages and the breadth of malignant diseases whose treatment
 may be compromised by the lack of drug availability.


Created 10-10-11. Clinical trial numbers current as of 11-14-11.

Accompanies the Fact Sheet “Drug Shortages Impacting Cancer Clinical Trials” Impacting Cancer Clinical Trials"

Download and print

Cancer Drug

Description of Drug

Common Uses In Cancer Treatment and Clinical Trials

Approximate Number of Clinical Trials Currently Open in the United States

Bleomycin injection

Bleomycin is an antineoplastic antibiotic used as a single agent or in combination with other antineoplastic agents


Hodgkin's disease and non-Hodgkin's lymphoma in adults

Testicular cancer in children and adults
Malignant pleural effusion (as a sclerosing agent)
Pleural effusion in children

Mycosis fungoides in adults

Osteosarcoma in adults
AIDS-related Kaposi sarcoma in adults
Lymphomas in children
Palliative therapy in adults with squamous cell carcinoma, including ovarian cancer and head
  and neck cancer
 

16

Capecitabine tablets

Capecitabine is a fluorouracil prodrug


Treatment of metastic colorectal cancer
An adjuvant to surgery in Dukes' C colon Cancer
Treatment-resistant metastatic breast cancer alone or in combination with docetaxel
Treatment-resistant, advanced or metastatic breast cancer in combination with lapatinib 
  or ixabepilone


94

Carboplatin solution for injection

Carboplatin is a platinum-containing alkylating agent


Ovarian Cancer in adults (single agent or combination therapy)
Small cell and non-small cell lung cancer in adults
Brain tumors in adults
Breast cancer in adults
Bladder cancer in adults
Cervical cancer in adults
Hodgkin's and non-Hodgkin's lymphoma in adults
Head and neck squamous cell cancer in adults
Neuroblastoma in adults
Testicular cancer in adults
Wilms" tumor in adults
Retinoblastoma in children

271

Cisplatin injection

Cisplatin is a platinum-based alkylating agent


Advanced transitional cell bladder cancer (single agent)
Metastatic testicular cancer (combination therapy)
Metastatic ovarian cancer (combination therapy)
Squamous cell head and neck cancer
Squamous cell head and ovarian cancer
Lung cancer
Osteosarcoma in children and adults
Esophageal cancer
Adrenal cortex carcinoma
Breast cancer
Endometrial cancer
Liver cancer
Brain tumors in children
With other drugs as a conditioning regimen prior to bone marrow transplantation

233

Cytarabine injection

Cytarabine is a pyrimidine antimetabolite used as a single agent or in combination with other antineoplastic agents


Acute myelocytic leukemia in children and adults
Acute myelocytic leukemia in children and adults
Chronic myelocytic leukemia in children and adults
Acute lymphocytic leukemia in children and adults
Meningeal leukemia in children and adults
Erythroleukemia in children and adults
Non-Hodgkin’s lymphoma in children and adults
Hodgkin’s lymphoma in adults
Hematopoietic stem cell transplantation in adults

126

    -Next Page-  
       

Cancer Drug

Description of Drug

Common Uses In Cancer Treatment and Clinical Trials

Approximate Number of Clinical Trials Currently Open in the United States

Dacarbazine injection

Dacarbazine is an alkylating agent


Malignant metastatic melanoma (single agent)
Hodgkin’s lymphoma in children and adults (combination therapy)
Medullary carcinoma of the thyroid in adults
Various soft tissue sarcomas in adults
Islet cell carcinoma in adults
Neuroblastoma in children
Solid tumors in children

86

Daunorubicin hydrochloride injection

Daunorubicin hydrochloride is an anthracycline antineoplastic antibiotic


Remission induction in adults with acute myelogenous
leukemia in combination with cytarabine
Remission induction in children, adolescents, and adults with acute lymphocytic leukemia in
  combination with 6 other drugs

Chronic myelogenous leukemia (combination therapy)
Neuroblastoma in children
Acute promyelocytic leukemia (combination therapy)
Anaplastic large cell lymphoma in children

26

Doxorubicin injection

Doxorubicin is an anthracycline glycoside agent


Leukemias in children and adults
Lymphomas in children and adults
Soft tissue and bone sarcomas in children and adults
Breast cancer in adults
Gastric cancer in adults
Ovarian cancer in adults
Thyroid cancer in adults
Small cell lung cancer in adults
Transitional bladder cancer in adults
AIDS-related Kaposi sarcoma in adults
Refractory multiple myeloma in adults
Ewing’s sarcoma in adults
Adrenocortical cancer in adults
Endometrial cancer in adults
Islet cell cancer in adults
Liver cancer in adults
Neuroblastoma in children
Wilms’ tumor in children

196 (includes doxorubicin liposomal injection)

Doxorubicin liposomal injection

Doxorubicin liposomal is an anthracycline glycoside agent encapsulated in liposomes


Refractory multiple myeloma in adults
Refractory ovarian cancer in adults
AIDS-related Kaposi sarcoma adults
Refractory metastatic breast cancer adults

See doxorubicin injection directly above

Etoposide injection

Etoposide is a podophyllotoxin antineoplastic agent


Testicular cancer
Small cell lung cancer
Bladder cancer
Acute myelocytic leukemia in children and adults
Lymphomas
Sarcomas
Brain tumors in children
Male and female reproductive system cancers
Non-small cell lung cancer
Gastric cancer
Wilms’ tumor
Multiple myeloma
Adenocarcinoma of unknown primary cancer
Hematopoietic stem cell transplantation

159

Fludarabine injection

Fludarabine is a purine antimetabolite


Progressive or refractory chronic B-cell lymphocytic
leukemia in adults (single agent or combination therapy)
Various leukemias in adults
Various acute leukemias in children
Non-Hodgkin’s lymphoma in adults
Waldenström macroglobulinemia in adults
Conditioning for hematopoietic stem cell transplantation in children and adults
Various solid tumors in children

183

    -Next Page-  
       

Description of Drug

Common Uses In Cancer Treatment and Clinical Trials

Approximate Number of Clinical Trials Currently Open in the United States

Fluorouracil injection

Fluorouracil is a pyrimidine antimetabolite


Colon cancer
Rectal cancer
Breast cancer
Stomach cancer
Pancreatic carcinoma
Head and neck cancer
Esophageal cancer
Anal cancer
Cervical cancer
Endometrial cancer
Ovarian cancer
Prostate cancer
Hepatic cancer
Bladder cancer
Renal cell carcinoma

173

Idarubicin hydrochloride injection

Idarubicin is a semisynthetic anthracycline


Acute myelocytic leukemia in adults (combination therapy)
Acute lymphocytic leukemia in children and adults
Chronic myelogenous leukemia in adults
Breast cancer in adults
Autologous hematopoietic stem cell transplantation in adults
Acute nonlymphocytic leukemia in children
Solid tumors in children

16

Irinotecan injection

Irinotecan is a topoisomerase type I DNA inhibitor most often used in combination with other antineoplastic agents


Metastatic colon and rectal cancer (combination therapy with fluorouracil and leucovorin
  as first-line treatment)

Recurrent or progressive colon or rectal cancer (single agent)
Cervical cancer
Gastric cancer
Lung cancer
Central nervous system tumors
Solid tumors in children

89

Leucovorin calcium injection

Leucovorin is a folinic acid product


Colorectal cancer in adults (combined with fluorouracil)
An alternative to oral therapy in the treatment of megaloblastic anemias due to folic acid
  deficiency

Methotrexate rescue in osteogenic sarcoma in children and adults
Toxicity reduction in patients with impaired methotrexate elimination
Toxicity reduction after inadvertent folic acid antagonist overdose
Methotrexate rescue in non-Hodgkin’s lymphoma

83

Mesna injection

Mesna is a prophylactic agent


Hemorrhagic cystitis reduction after treatment with ifosfamide, an antineoplastic alkylating
  agent used to treat various cancers


39

Methotrexate injection

Methotrexate is an antimetabolite that inhibits dihydrofolic acid reductase


Breast cancer
Epidermoid cancers of the head and neck
Advanced mycosis fungoides (cutaneous T-cell lymphoma)
Lung cancer
Advanced non-Hodgkin’s lymphomas (combination therapy)
Meningeal leukemia (intrathecal)
Soft tissue sarcoma

108

-Next Page-
       

Cancer Drug

Description of Drug

Common Uses In Cancer Treatment and Clinical Trials

Approximate Number of Clinical Trials Currently Open in the United States

Mitomycin injection

Mitomycin is an antineoplastic antibiotic


Palliative treatment of disseminated adenocarcinoma of the stomach or pancreas in adults (combination therapy)
Mesothelioma in adults
Squamous cell carcinoma of the head and neck, lungs, or cervix in adults
Anal cancer in adults
Bladder cancer in adults (intravesicular use)
Breast cancer in adults
Colorectal cancer in adults
Hepatocellular cancer in adults (intraarterial use)

10

Octreotide injection

Octreotide is an octapeptide that mimics naturally occurring somatostatin


Long-term treatment of severe diarrhea and flushing associated with metastatic carcinoid tumors
Long-term treatment of watery diarrhea associated with vasoactive intestinal peptide-secreting tumors

10

Paclitaxel injection

Paclitaxel is a mitotic inhibitor


Ovarian cancer (single agent)
Breast cancer (single agent)
Adjuvant therapy in breast cancer
Non-small cell lung cancer (combination therapy)
AIDS-related Kaposi sarcoma in adults (single agent)
Bladder cancer in adults
Prostate cancer in adults
Testicular cancer in adults
Esophageal cancer in adults
Endometrial cancer in adults
Cervical cancer in adults
Squamous cell head and neck cancer in adults
Small cell lung cancer in adults
Gastric cancer in adults
Germ cell tumors in adults
Refractory leukemia in children
Recurrent Wilms’ tumor in children

267

Thiotepa injection

Thiotepa is a cytotoxic agent related chemically and pharmacologically to nitrogen mustard


Superficial papillary carcinoma of the urinary bladder
Lymphomas, including lymphosarcoma and Hodgkin’s lymphoma
Palliation of adenocarcinoma of the breast
Palliation of adenocarcinoma of the ovary
Control of intracavitary effusions secondary to diffuse or localized neoplastic diseases of serosal cavities

34

Vincristine injection

Vincristine is an antineoplastic vinca alkaloid agent


Acute leukemia
Hodgkin’s lymphoma (combination therapy)
Non-Hodgkin’s lymphoma (combination therapy)
Rhabdomyosarcoma (combination therapy)
Neuroblastoma (combination therapy)
Wilms’ tumor (combination therapy)
Kaposi sarcoma
Breast cancer
Bladder cancer
Small cell lung carcinoma
Brain tumors
Multiple myeloma
Chronic lymphocytic leukemia
Chronic myelocytic leukemia

119


Sources:

 American Society of Health-System Pharmacists. Current drug shortage bulletins. Available at: http://www.ashp.org/DrugShortages/Current/. Accessed October 7, 2011.

[Note: The individual bulletins are derived from the American Hospital Formulary Service Drug Information Manual, which is published by the American Society of Health-System Pharmacists.]

 US National Institutes of Health. Search for clinical trials. Available at: clinicaltrials.gov. Accessed November 14, 2011. Search terms used to determine the number of clinical trials by drug are as follows:  main search term = drug name (without descriptors such as injection, tablets, etc.); recruitment = open studies (open recruitment status included trials that were recruiting, not yet recruiting, and available for expanded access); unknown status = excluded; study results = all studies; study type = all studies; conditions = cancer; and locations = United States.

 Disclaimer:  Drug usage is a complex medical decision and users of the information provided here should exercise their own independent judgment. This information should not in any way be interpreted as “advice” for the prescription of medication for any of the conditions listed. The intent of this chart is to raise public awareness about the magnitude of cancer drug shortages and the breadth of malignant diseases whose treatment may be compromised by the lack of drug availability.